Abstract:Context: Polycystic ovary syndrome (PCOS) is a heterogeneous disorder, with disease loci identified from genome-wide association studies (GWAS) having largely unknown relationships to disease pathogenesis. Objective: This work aimed to group PCOS GWAS loci into genetic clusters associated with disease pathophysiology. Methods: Cluster analysis was performed for 60 PCOS-associated genetic variants and 49 traits using GWAS summary statistics. Cluster-specific PCOS partitioned polygenic scores (pPS) were generated and tested for association with clinical phenotypes in the Mass General Brigham Biobank (MGBB, N = 62 252). Associations with clinical outcomes (type 2 diabetes [T2D], coronary artery disease [CAD], and female reproductive traits) were assessed using both GWAS-based pPS (DIAMANTE, N = 898,130, CARDIOGRAM/UKBB, N = 547 261) and individual-level pPS in MGBB. Results: Four PCOS genetic clusters were identified with top loci indicated as following: (i) cluster 1/obesity/insulin resistance (FTO); (ii) cluster 2/hormonal/menstrual cycle changes (FSHB); (iii) cluster 3/blood markers/inflammation (ATXN2/SH2B3); (iv) cluster 4/metabolic changes (MAF, SLC38A11). Cluster pPS were associated with distinct clinical traits: Cluster 1 with increased body mass index (P = 6.6 × 10-29); cluster 2 with increased age of menarche (P = 1.5 × 10-4); cluster 3 with multiple decreased blood markers, including mean platelet volume (P = 3.1 ×10-5); and cluster 4 with increased alkaline phosphatase (P = .007). PCOS genetic clusters GWAS-pPSs were also associated with disease outcomes: cluster 1 pPS with increased T2D (odds ratio [OR] 1.07; P = 7.3 × 10-50), with replication in MGBB all participants (OR 1.09, P = 2.7 × 10-7) and females only (OR 1.11, 4.8 × 10-5). Conclusion: Distinct genetic backgrounds in individuals with PCOS may underlie clinical heterogeneity and disease outcomes.

Genome-Wide Association Studies for Polycystic Ovary Syndrome

Genetic Studies on Polycystic Ovary Syndrome

The Genetics of Polycystic Ovary Syndrome: An Overview of Candidate Gene Systematic Reviews and Genome-Wide Association Studies

Molecular genetics of polycystic ovary syndrome: an update

The Association Between Polymorphism Of Insr And Polycystic Ovary Syndrome: A Meta-Analysis

Genetic determinants of polycystic ovary syndrome: progress and future directions

Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

Advances in Molecular Genetic Study on PCOS

Identifying Novel Genetic Loci Associated with Polycystic Ovary Syndrome Based on Its Shared Genetic Architecture with Type 2 Diabetes.

Polycystic Ovary Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci

Systematic Evaluation of Genetic Variants for Polycystic Ovary Syndrome in a Chinese Population.

Association Between Common Genetic Variants and Polycystic Ovary Syndrome Risk in a Chinese Han Population.

A Comprehensive Overview of Common Polymorphic Variants in Genes Related to Polycystic Ovary Syndrome

Genome-wide linkage and association study identifies novel genes and pathways implicated in polycystic ovarian syndrome

Colocalization analysis of polycystic ovary syndrome to identify potential disease-mediating genes and proteins

Integrated Analyses for Genetic Markers of Polycystic Ovary Syndrome with 9 Case-Control Studies of Gene Expression Profiles

A Molecular and Cellular Review of the Literature

An Association Study Between USP34 and Polycystic Ovary Syndrome

Body mass index stratified meta-analysis of genome-wide association studies of polycystic ovary syndrome in women of European ancestry

Genome-wide association study for SNPs associated with PCOS in human patients

Genome-Wide Association Study Identifies Susceptibility Loci for Polycystic Ovary Syndrome on Chromosome 2p16.3, 2p21 and 9Q33.3